Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wisconsin Technology Today.
Press releases published on February 25, 2026
Feb. 25, 2026
CEA Industries CEO David Namdar Issues Letter to Shareholders
Indeterminate
GlobeNewswire
Feb. 25, 2026
ARRAY Technologies Reports Financial Results for the Fourth Quarter and Full Year 2025
Indeterminate
GlobeNewswire
Feb. 25, 2026
Climb Global Solutions Reports Fourth Quarter and Full Year 2025 Results
Indeterminate
GlobeNewswire
Feb. 25, 2026
Korro to Present at the TD Cowen 46th Annual Health Care Conference
Indeterminate
GlobeNewswire
Feb. 25, 2026
Commerce to Present at Upcoming Investor Conference
Indeterminate
GlobeNewswire
Feb. 25, 2026
Enovix Reports Fourth Quarter and Full Year 2025 Results
Indeterminate
GlobeNewswire
Feb. 25, 2026
Zoom Communications Reports Fourth Quarter and Fiscal Year 2026 Financial Results
Indeterminate
GlobeNewswire
Feb. 25, 2026
Veeco Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Indeterminate
GlobeNewswire
Feb. 25, 2026
Magnite Reports Fourth Quarter and Full-Year 2025 Results
Indeterminate
GlobeNewswire
Feb. 25, 2026
PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance
Indeterminate
GlobeNewswire
Feb. 25, 2026
Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference
Indeterminate
GlobeNewswire
Feb. 25, 2026
Celldex Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire
Feb. 25, 2026
Nutanix Reports Second Quarter Fiscal 2026 Financial Results
Indeterminate
GlobeNewswire
Feb. 25, 2026
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering
Indeterminate
GlobeNewswire
Feb. 25, 2026
Arcutis Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Indeterminate
GlobeNewswire
Feb. 25, 2026
SPARC AI Enters Ukrainian Defence Market with Strategic Reseller Partnership
Indeterminate
GlobeNewswire
Feb. 25, 2026
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution
Indeterminate
GlobeNewswire